Rhythm Pharmaceuticals buy The Goldman Sachs Group, Inc.
Start price
25.01.24
/
50%
€40.80
Target price
25.01.25
€47.88
Performance (%)
20.10%
Price
03.10.24
€44.73
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 20.10%. This prediction currently runs until 25.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $42.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€35.40
07.12.23
07.12.23
€38.96
07.12.24
07.12.24
38.42%
03.10.24
03.10.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€23.20
02.03.23
02.03.23
€42.45
02.03.24
02.03.24
69.83%
03.03.24
03.03.24